China's AI Advantage: How US Bans Fuel a Rival Tech Empire
US restrictions meant to slow China's AI are instead fueling its self-sufficiency. Founders: Cling's $18B valuation proves the shift. Look east.
Enterprises Fear Frontier Models | Sam Altman Offers Trump 5% of OpenAI | DeepSeek Builds Own Chips
With Harry Stebbings, Rory, Jason · Sunday, July 12, 2026
This episode delves into the evolving landscape of AI, examining the US government's increasing involvement through regulation and potential ownership stakes in companies like OpenAI. It also explores enterprise skepticism regarding AI ROI and data privacy, the strategic moves of hyperscalers in selling excess compute, and the trend of LLM providers building custom chips. The discussion highlights the unique dynamics of China's AI market and the challenges and future of enterprise AI adoption.
AI's $2.5B Enterprise Service Play: Why It'll Fail
Microsoft and Amazon are embedding engineers to fix AI adoption. But a severe talent gap means their multi-billion dollar bet on services might be doomed.
Why Enterprises Doubt Frontier AI: ROI & IP Risk
Large enterprises are skeptical of frontier AI models from OpenAI and Anthropic, citing questionable ROI and fear of IP theft. Founders, understand this trust gap.
AI Founders Welcome Extreme Dilution: Why 1.7% is the New 20%
AI founders like Anthropic's Dario Amodei hold minimal equity. Learn why extreme dilution is now institutionalized and what it means for your next round.
Meta Sells Excess AI Compute: Is This Gold Mine or Glut?
Meta and SpaceX are monetizing excess AI compute, boosting stock but signaling potential market oversupply. Founders, beware of future price drops.
Anthropic, DeepSeek Build Chips: Control or Margin Grab?
LLM giants Anthropic and DeepSeek are building custom AI chips. Is it for strategic control and optimization, or a play to capture Nvidia's massive margins?
OpenAI's 5% Gov Stake: Absurd Concession or Strategic Anchor?
Washington now requires pre-approval for AI software. Was Sam Altman's 5% stake offer to the US government a misstep or a brilliant strategic play?